Europe Advances Review Of Pfizer’s Covid-19 Vaccine As Pressure Mounts-The Wall Street Journal

The European Union’s chief drug regulator will accelerate its review of a Covid-19 vaccine after coming under pressure from some governments to authorize the shot, as the continent struggles to contain a wave of cases ahead of the Christmas period. The European Medicines Agency said on Tuesday it would meet on Dec. 21, eight days earlier than previously scheduled, to consider authorizing the shot developed by Germany’s BioNTech SE and Pfizer Inc. The Wall Street Journal, 12/15/2020

•   Print
•   Email
•   Share
•   Tweet